• SENSEX 80,298.65
    10.27 (+0.01%)
  • BANKNIFTY 55,391.25
    -41.55 (--0.07%)
  • Mazagon Dock
    3,149.70 3,047.00(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Cochin Shipyard
    1,600.40 1,169.00(%)
  • Torrent Pharma.
    3,360.00 3,589.95(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Tata Motors
    642.75 542.55(%)
  • Samvardh. Mothe.
    132.45 107.30(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Data Pattern
    2,459.05 1,350.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • IndusInd Bank
    810.40 605.40(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,134.00 4,058.45(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • ICICI Bank
    1,433.10 1,438.15(%)
  • HDFC Bank
    1,936.40 1,977.95(%)
  • Vishal Mega Mart
    118.35 126.85(%)
  • Godrej Propert.
    2,236.90 3,400.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Alembic Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 40294.0
  • ISIN : INE901L01018
879.80 9 (1.05%)
  • As on 30 Apr 2025 (EOD)
  • Today’s Low

    870.70
  • Today’s High

    885.65
  • Open

    870.70
  • Perv Close

    870.70
  • 52W Low

    725.20
  • 52W High

    1,303.90

Key Indicators

  • P/E(TTM)

    27.92

  • Mar.Cap (₹Cr.)

    17,293.62

  • Div & Yield %

    1.25

  • Book Value(₹)

    255.98

  • Debt-Equity Ratio

    1.05

  • AGM Date

    29-Apr-2025

  • EPS

    31.49

  • P/E Ratio

    27.92

Financials Ratios

  • Debt-Equity Ratio

    0.13

  • Mar.Cap (₹Cr.)

    17,293.62

  • RONW (%)

    13.40

  • ROCE (%)

    12.93

Score Board

  • Equity (₹ in Cr.)

    39.31

  • BV (₹)

    256.00

  • Sales( ₹ in Cr.)

    5,874.06

  • NP (in Cr.)

    665.49

  • NP Var(%)

    92.0

  • Div%

    550.0

  • CPS (₹)

    47.70

  • EPS (₹)

    33.90

  • Traded Value (₹ in Lakhs)

    17,282.81

  • 52 Week High

    1,303.90

  • 52 Week Low

    725.20

  • Price BSE

    879.0

  • Price NSE

    880.00

  • Market Capital( in Cr.)

    17,282.81

  • P/C Ratio

    18.40

  • P/E Ratio

    26.00

  • Price Vs.BV

    33.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 5,874.06 5,149.00 5,035.41 5,066.89 4,132.55 3,660.27
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 5,874.06 5,149.00 5,035.41 5,066.89 4,132.55 3,660.27
Other Income 31.32 3.54 51.14 83.90 134.75 6.42
Stock Adjustments 52.36 -72.84 -19.85 160.65 176.50 80.42
Total Income 5,957.74 5,079.70 5,066.70 5,311.44 4,443.80 3,747.11
EXPENDITURE :            
Raw Materials 1,852.71 1,587.29 1,482.36 1,464.67 1,222.39 1,080.49
Power and Fuel Cost 173.32 151.19 120.50 118.31 97.43 88.44
Employee Cost 1,335.91 1,094.82 1,062.30 976.13 806.37 684.45
Other Manufacturing Expenses 327.87 357.21 324.10 344.44 291.44 233.95
Selling and Administration Expenses 1,191.90 1,173.00 1,088.67 848.55 661.00 762.72
Miscellaneous Expenses 46.19 48.31 28.82 26.07 37.52 11.97
Employee Benefit Expenses 1,335.91 1,094.82 1,062.30 976.13 806.37 684.45
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 4,927.90 4,411.82 4,106.75 3,778.17 3,116.15 2,862.02
Operating Profit 1,029.84 667.88 959.95 1,533.27 1,327.65 885.09
Interest 54.47 49.00 17.02 12.98 25.19 14.87
Gross Profit 975.37 618.88 942.93 1,520.29 1,302.46 870.22
Depreciation 271.14 272.95 284.92 182.55 135.67 105.59
Profit Before Tax 704.23 345.93 658.01 1,337.74 1,166.79 764.63
Current Tax 37.75 -0.80 114.46 241.20 197.39 153.42
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 666.48 346.73 543.55 1,096.54 969.40 611.21
Extraordinary Items 0.99 0.05 2.81 5.20 -7.06 2.15
Adjusted Net Profit 665.49 346.68 540.74 1,091.34 976.46 609.06
Adjustment below Net Profit 0.00 0.00 -76.31 -114.90 -51.00 -43.57
P & L Balance brought forward 3,651.68 2,632.89 2,440.83 1,709.19 1,296.49 919.76
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 157.25 -672.07 275.19 250.00 525.97 190.91
P & L Balance carried down 4,160.91 3,651.69 2,632.88 2,440.83 1,688.92 1,296.49
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 550.00 400.00 500.00 700.00 500.00 275.00
Dividend Per Share(Rs) 11.00 8.00 10.00 14.00 10.00 5.50
Earnings Per Share-Unit Curr 33.91 17.64 27.65 55.79 51.43 32.42
Earnings Per Share(Adj)-Unit Curr 33.91 17.64 27.65 55.79 51.43 32.42
Book Value 249.75 224.59 269.16 259.57 177.51 143.89
Book Value(Adj)-Unit Curr 249.75 224.59 269.16 259.57 177.51 143.89

Shareholding Pattern

  • Promoter Group

    69.67%

  • Public Share Holding

    30.33%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 1,006,980 1,006,980.00 1,006,980 1,006,980
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 1,006,980 0.51 1,006,980 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 126,145,834 64.18 126,145,834 7
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,641,976 4.91 9,641,976 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 150,900 0.08 150,900 7
Others 0 0.00 0 0
Sub Total 135,939,610 69.16 135,939,610 26
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 53,650 0.03 38,550 7
Foreign Bank 3,250 0.00 3,250 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,748,624 3.94 7,748,624 149
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 13,526,957 6.88 13,526,957 10
Mutual Funds / UTI 18,074,308 9.20 18,074,308 21
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 639,013 0.33 639,013 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 40,045,802 20.37 40,030,702 198
2] Non Institution
Bodies Corporate 322,336 0.16 314,136 350
Clearing Members 249 0.00 249 5
Directors of their Relatives 2,409,078 1.23 2,409,078 4
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 895,444 0.46 892,969 1,979
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 411,073 0.21 410,233 1,586
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,239,220 0.63 1,239,220 6
Individuals holding nominal share capital up to Rs. 1 lakh 12,663,010 6.44 11,659,634 87,142
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 24,541 0.01 24,541 8
Others 1,538,520 0.78 1,538,520 1
Sub Total 19,570,732 9.96 18,555,841 91,111
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 196,563,124 100.00 195,533,133 91,336

Company Background

Alembic Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Alembic Pharmaceuticals Ltd
  • BSE Code : 40294.0
  • ISIN : INE901L01018
  • Incorporation Year

    2010

  • Registered Office

    Alembic Road
    , Vadodara,
    Gujarat-390003

  • Telephone

    91-0265-2280550

  • FAX

    91-0265-2282506

  • Chairman

    Chirayu R Amin

  • Managing Director

    Pranav Amin

  • Company Secretary

    Manisha Saraf

  • Auditor

    K C Mehta & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    B-102&103 Shangrila,
    Complex First Floor,Akota
    Mumbai - Vadodara - 390 020

Alembic Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Alembic Pharma 879.25 5,905.38 5,874.06 27.45 14.13
Abbott India 30,094.35 6,097.18 5,848.91 47.92 44.71
Astrazeneca Phar 8,795.90 1,330.33 1,295.53 226.76 33.26
P & G Health Ltd 5,121.00 1,166.89 1,151.26 35.93 39.76
Glaxosmi. Pharma 2,904.45 3,530.73 3,407.25 57.75 44.44
Cipla 1,541.00 17,645.00 16,574.34 26.42 20.10
Amrutanjan Healt 679.10 437.58 421.23 39.81 20.84
Guj. Themis Bio. 285.15 174.19 169.82 59.04 44.82
Fermenta Biotec. 272.25 315.24 307.09 25.81 4.10
Bliss GVS Pharma 122.65 638.96 605.46 28.07 11.19
Ambalal Sarabhai 37.10 11.70 3.81 15.85 1.92